The Impact of Positron Emission Tomography with 18 F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial Article Swipe
Related Concepts
Gerald L. Andriole
,
Lale Kostakoğlu
,
Albert Chau
,
Fenghai Duan
,
Umar Mahmood
,
David A. Mankoff
,
David M. Schuster
,
Barry A. Siegel
,
Lee P. Adler
,
Laurence Belkoff
,
Daniel Burzon
,
Paul Dato
,
Michael D. Farwell
,
Stephen Fogelson
,
Peter Gardiner
,
Lucy Hanna
,
John M. Hoffman
,
Charles Intenzo
,
David Josephson
,
Jed Kaminetsky
,
Michael S. Kipper
,
Borys R. Krynyckyi
,
Karen E. Linder
,
Helga S. Marques
,
John Melnick
,
Matthew P. Miller
,
William Oh
,
Shaile Philips
,
Judith S. Rose
,
Bital Savir-Baruch
,
Daniel Stevens
,
Ashutosh Tewari
,
Przemyslaw Twardowski
,
Penelope Ward
,
Martha Wasserman
,
Sharon Weick
,
Jian Q. Yu
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1016/j.juro.2018.08.050
· OA: W2889050620
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1016/j.juro.2018.08.050
· OA: W2889050620
F-fluciclovine positron emission tomography/computerized tomography detected 1 or more recurrence sites in the majority of men with biochemical recurrence, frequently resulting in major changes to management plans. Future studies will be planned to determine whether a management change leads to improved outcomes.
Related Topics
Finding more related topics…